[1] FUNG M K,EDER A F,SPITALNIK S L,et al.Technical Manual[M].19th ed.Bethesda,MD: AABB,2017: 683-694. [2] TOPCUOGLU P.Transfusion policy in allogeneic hematopoietic stem cell transplantation[J].Transfus Apher Sci,2018,57(2):174-177. [3] ALLEN E S,SRIVASTAVA K,HSIEH M M,et al.Immunohaematological complications in patients with sickle cell disease after haemopoietic progenitor cell transplantation:a prospective,single-centre,observational study[J].Lancet Haematol,2017,4(11):e553-e561. [4] BADER P,KLINGEBIEL T,SCHAUDT A,et al.Preventi on of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism:a single center experience of 12 children[J].Leukemia,1999,13(12):2079-2086. [5] TANG X W,ALATRASH G,NING J,et al.Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time[J].Biol Blood Marrow Transplant,2014,20(8):1139-1144. [6] 范辉,朱宏丽,卢学春,等.ABO血型不合对异基因造血干细胞移植的影响[J].中国组织工程研究与临床康复,2008,12(3):481-484. [7] 余忠清,程汉华,陈凤花,等.异基因造血干细胞移植ABO转型特征与免疫相关性疾病的防治策略[J].中华临床医师杂志(电子版),2013,7(5):1852-1855. [8] 闫石,韩明哲,焦淑贤,等.ABO血型不合的干细胞移植后血清凝集素的变化[J].中国输血杂志,2000,13(3):174-175. [9] PRUSS A,HEYMANN G A,HELL A,et al.Acute intravascular hemolysis after transfusion of a chimeric RBC unit[J].Transfusion,2003,43(10):1449-1451. [10] WANG J Y,YUAN M,ZHU G H,et al.Immune reconstitution in pediatric aplastic Anemia after allogeneic hematopoietic stem-cell transplantation[J].Int J Med Sci,2022,19(5):821-828. [11] MELLGREN K,NIEROP A F M,ABRAHAMSSON J.Use of multivariate immune reconstitution patterns to describe immune reconstitution after allogeneic stem cell transplantation in children[J].Biol Blood Marrow Transplant,2019,25(10):2045-2053. [12] BHATT S T,BEDNARSKI J J.Immune reconstitution in pediatric patients following hematopoietic cell transplant for non-malignant disorders[J].Front Immunol,2020,11:1988. [13] 王蕊,温丙昭,曲建华,等.ABO血型不合的外周血干细胞移植及输血[J].白血病淋巴瘤,2004,13(3):139-141. [14] TASAKI T,SATOH S,GOTOH K,et al.Transfusion-related problems following major ABO-incompatible bone marrow transplantation[J].Transfus Apher Sci,2003,28(2):155-161. |